Should Hungary Pay More for a QALY Gain than Higher-Income Western European Countries?

ABSTRACT:

Objectives

Cost-effectiveness thresholds (CETs) play a particularly important role in the reimbursement decisions of health technologies in countries with limited healthcare resources. Our goal is to develop a scientifically solid proposal for a revised cost-effectiveness threshold, as part of the planned review of the Hungarian health economic guidance.

Methods

The Threshold Working Group of the Hungarian Health Economics Association performed a targeted review on CETs in European countries. International trends on CETs served as a basis for our recommendation, which was discussed at the Association's workshop and deliberated at an expert committee meeting with representatives from the national health technology assessment (HTA) and healthcare payer bodies, and academic HTA

SUBMITTER: Kovacs S 

PROVIDER: S-EPMC9021143 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature